Abstract
While the promise of precision medicine has generated excitement and high expectations, there are challenges for some key assumptions on which the concept is based. Since most common and complex diseases belong to adaptive systems where fuzzy inheritance interacts with the dynamic environment during nonlinear somatic cell evolution, both disease progression and treatment response are less predictable if based only on the precision of gene profiles. Although increased voices have expressed their concerns for this neo-reductionist approach (reduction based on big data), few have directly studied the conceptual limitations of precision medicine. In this chapter, we will focus on the relationship between bio-heterogeneity and emergent properties, a subject crucial to understanding why the targeting of lower-level agents (genes and pathways) provides unsatisfactory results at higher levels of this system such as clinical outcomes, which is practically the ultimate goal. Such analyses illustrate that dynamic interactions of heterogeneity in lower-level agents lead to the unpredictability of complex adaptive systems. As a result, stress-induced multiple genomic heterogeneity-mediated evolutionary processes present the greatest challenges for precision medicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Endoplasmic reticulum.
- 2.
Mitochondrial DNA.
- 3.
Homologous recombination: a type of genetic recombination in which nucleotide sequences are exchanged between two similar or identical molecules of DNA, particularly to repair DNA damage affecting both strands of the double helix.
References
Heng HH. The genome-centric concept: resynthesis of evolutionary theory. Bioessays. 2009;31(5):512–25.
Heng HH. Cancer genome sequencing: the challenges ahead. Bioessays. 2007:29(8):783–94.
Heng HH. Debating cancer: the paradox in cancer research. Hackensack, NJ: World Scientific; 2015.
Heng HH, Stevens JB, Liu G, Bremer SW, Ye KJ, Reddy PV, et al. Stochastic cancer progression driven by non-clonal chromosome aberrations. J Cell Physiol. 2006;208(2):461–72.
Heng HH. The conflict between complex systems and reductionism. JAMA. 2008;300(13):1580–1.
Kolodkin A, Simeonidis E, Westerhoff HV. Computing life: add logos to biology and bios to physics. Prog Biophys Mol Biol. 2014;111(2–3):69–74.
Heng HH, Bremer SW, Stevens JB, Horne SD, Liu G, Abdallah BY, et al. Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution. Cancer Metastasis Rev. 2013;32(3–4):325–40.
Heng HH, Liu G, Stevens JB, Bremer SW, Ye KJ, Abdallah BY, et al. Decoding the genome beyond sequencing: the new phase of genomic research. Genomics. 2011;98(4):242–52.
Heng HH, Liu G, Stevens JB, Abdallah BY, Horne SD, Ye KJ, et al. Karyotype heterogeneity and unclassified chromosomal abnormalities. Cytogenet Genome Res. 2013;139(3):144–57.
Heng HH, Regan SM, Liu G, Ye CJ. Why it is crucial to analyze non clonal chromosome aberrations or NCCAs? Mol Cytogenet. 2016;9:15.
Ye CJ, Regan S, Liu G, Alemara S, Heng HH. Understanding aneuploidy in cancer through the lens of system inheritance, fuzzy inheritance and emergence of new genome systems. Mol Cytogenet. 2018;11:31.
Ye CJ, Liu G, Bremer SW, Heng HH. The dynamics of cancer chromosomes and genomes. Cytogenet. Genome Res. 2007;118(2–4):237–46.
Heng HH. Genome chaos: rethinking genetics, evolution, and molecular medicine. Cambridge: Academic Press; 2019.
Liu G, Ye CJ, Chowdhury SK, Abdallah BY, Horne SD, Nichols D, et al. Detecting chromosome condensation defects in Gulf war illness patients. Curr Genet. 2018;19(3):200–6.
Heng HH, Liu G, Regan S, Ye CJ. Linking Gulf war illness to genome instability, somatic evolution, and complex adaptive systems. In: Sturmberg J, editor. Putting systems and complexity sciences into practice. Cham: Springer; 2018. p. 83–95.
Wallace DC, Chalkia D. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol. 2013;5(11):a021220.
Picard M, Zhang J, Hancock S, Derbeneva O, Golhar R, Golik P, et al. Progressive increase in mtDNA 3243A> G heteroplasmy causes abrupt transcriptional reprogramming. Proc Natl Acad Sci USA. 2014;111(38):E4033–42.
Abdallah BY, Horne SD, Stevens JB, Liu G, Ying AY, Vanderhyden B, et al. Single cell heterogeneity: why unstable genomes are incompatible with average profiles. Cell Cycle 2013;12(23):3640–9.
Liu G, Stevens JB, Horne SD, Abdallah BY, Ye KJ, Bremer SW, et al. Genome chaos: survival strategy during crisis. Cell Cycle. 2014;13(4):528–37.
Ye CJ, Liu G, Heng HH. Experimental induction of genome chaos. Methods Mol. Biol. 2018;1769:337–52.
Pal J, Nanjappa P, Kumar S, Shi J, Buon L, Munshi NC, et al. Impact of RAD51C-mediated homologous recombination on genomic integrity in Barrett’s adenocarcinoma cells. J Gastroenterol Hepatol Res. 2017;6(1):2286–95.
Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144(1):27–40.
Baca SC, Prandi D, Lawrence MS, Mosquera JM, Romanel A, Drier Y, et al. Punctuated evolution of prostate cancer genomes. Cell. 2013;153(3):666–77.
Luo J, Sun X, Cormack BP, Boeke JD. Karyotype engineering by chromosome fusion leads to reproductive isolation in yeast. Nature. 2018;560(7718):392–96.
Shao Y, Lu N, Wu Z, Cai C, Wang S, Zhang LL, et al. Creating a functional single-chromosome yeast. Nature. 2018;560(7718):331–5.
Heppner GH, Miller BE. Therapeutic implications of tumor heterogeneity. Semin Oncol. 1989;16(2):91–105.
Cleary AS, Leonard TL, Gestl SA, Gunther EJ. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature. 2014;508(7494):113–7.
Campbell K, Vowinckel J, Ralser M. Cell-to-cell heterogeneity emerges as consequence of metabolic cooperation in a synthetic yeast community. Biotechnol J 2016;11(9):1169–78.
Heng HH. Heterogeneity-mediated cellular adaptation and its trade-off: searching for the general principles of diseases. J Eval Clin Pract. 2017;23(1):233–7.
Horne SD, Chowdhury SK, Heng HH. Stress, genomic adaptation, and the evolutionary trade-off. Front Genet. 2014;5:92.
Heng HH, Regan S, Ye CJ. Genotype, environment, and evolutionary mechanism of diseases. Environ Dis. 2016;1(1):14–23.
Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793–5.
Heng HH. Bio-complexity challenging reductionism. In: Sturmberg JS, Martin CM, editors. Handbook of systems and complexity in health. New York: Springer; 2013. p. 193–208.
Sturmberg JS, Martin CM, editors. Handbook of systems and complexity in health. New York: Springer; 2013.
Sturmberg JP, Bennett JM, Martin CM, Picard M. ‘Multimorbidity’ as the manifestation of network disturbances. J Eval Clin Pract. 2017;23(1):199–208.
Acknowledgement
This chapter is part of a series of studies entitled “The mechanisms of somatic cell and organismal evolution.”
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Heng, H.H., Liu, G., Alemara, S., Regan, S., Armstrong, Z., Ye, C.J. (2019). The Mechanisms of How Genomic Heterogeneity Impacts Bio-Emergent Properties: The Challenges for Precision Medicine. In: Sturmberg, J. (eds) Embracing Complexity in Health. Springer, Cham. https://doi.org/10.1007/978-3-030-10940-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-10940-0_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10939-4
Online ISBN: 978-3-030-10940-0
eBook Packages: MedicineMedicine (R0)